AsOf

Recorded or changed on this day 2026-11-08

45,001–45,050 of 46,534 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,264,888,000 United States dollar
Vertex Pharmaceuticals total equity: 1,264,888,000 United States dollar, claim clm_6D0B6A2430B2 · ended · superseded by clm_260A5D665F9C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -14,330,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -14,330,000 United States dollar, claim clm_6D374A34EDA7 · ended · superseded by clm_2228EE6A3A62 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 13,912,700,000 United States dollar
Vertex Pharmaceuticals total equity: 13,912,700,000 United States dollar, claim clm_6D580D76E517 · ended · superseded by clm_259DCABF6218 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 22,240,200,000 United States dollar
Vertex Pharmaceuticals total assets: 22,240,200,000 United States dollar, claim clm_6D94781B6A40 · ended · superseded by clm_F4271585E734 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 246,284,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 246,284,000 United States…, claim clm_6E79D9B514B1 · ended · superseded by clm_08C42F082050 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 243,197,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 243,197,000 United States dollar, claim clm_6F397338265E · ended · superseded by clm_F97987974B05 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -160,282,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -160,282,000 United States dollar, claim clm_6F9D9EB7890A · ended · superseded by clm_66CCBB904B9A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 391,672,000 United States dollar
Vertex Pharmaceuticals total equity: 391,672,000 United States dollar, claim clm_6FF0398AE57E · ended · superseded by clm_1F567078AF69 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 4,569,600,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 4,569,600,000 United States dollar, claim clm_7036AF53899D · ended · superseded by clm_D421BB040AD7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 396,547,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 396,547,000 United States dollar, claim clm_704DCF1A9448 · ended · superseded by clm_FFDB6607C3CE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 118,451,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 118,451,000 United States dollar, claim clm_70C273FE1AD2 · ended · superseded by clm_52B14B1D462C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 216,827,066 shares
Vertex Pharmaceuticals shares outstanding: 216,827,066 shares, claim clm_70D8F6354992 · ended · superseded by clm_C9B18373B83D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 604,245,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 604,245,000 United States dollar, claim clm_70FFDCCAA48B · ended · superseded by clm_1C6CC599E968 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 6,205,683,000 United States dollar
Vertex Pharmaceuticals revenue: 6,205,683,000 United States dollar, claim clm_710D5BB40195 · ended · superseded by clm_054958897891 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 3,397,941,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 3,397,941,000 United States dollar, claim clm_713E0D0A2043 · ended · superseded by clm_8D8808029B98 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -95,149,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -95,149,000 United States dollar, claim clm_716BECC984E5 · ended · superseded by clm_D76BCB337804 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 1,770,302,000 United States dollar
Vertex Pharmaceuticals total assets: 1,770,302,000 United States dollar, claim clm_71D593846901 · ended · superseded by clm_5B82DB4B1ACF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 550,274,000 United States dollar
Vertex Pharmaceuticals research and development: 550,274,000 United States dollar, claim clm_7210AEE2240D · ended · superseded by clm_7AB4898F104F · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · ticker · VRTX
Vertex Pharmaceuticals ticker: VRTX, claim clm_725C8AE3FDC6 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 918,783,000 United States dollar
Vertex Pharmaceuticals research and development: 918,783,000 United States dollar, claim clm_727E384A5333 · ended · superseded by clm_2F6A721A75E3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 101,889,000 United States dollar
Vertex Pharmaceuticals revenue: 101,889,000 United States dollar, claim clm_72998EF97E5B · ended · superseded by clm_A50C566EACEB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · -692,412,000 United States dollar
Vertex Pharmaceuticals operating income: -692,412,000 United States dollar, claim clm_729B31AEC767 · ended · superseded by clm_B6F6CDFC9E0A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 3,198,325,000 United States dollar
Vertex Pharmaceuticals total assets: 3,198,325,000 United States dollar, claim clm_72B030278F2C · ended · superseded by clm_0222BA7D9859 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 138,509,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 138,509,000 United States dollar, claim clm_72E202E696DB · ended · superseded by clm_26173C591341 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,037,773,000 United States dollar
Vertex Pharmaceuticals total equity: 1,037,773,000 United States dollar, claim clm_72E671723425 · ended · superseded by clm_DD677E25C8F6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 3,294,684,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 3,294,684,000 United States dollar, claim clm_73E5227A4A27 · ended · superseded by clm_713E0D0A2043 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 244,655,527 shares
Vertex Pharmaceuticals shares outstanding: 244,655,527 shares, claim clm_74711F790F20 · ended · superseded by clm_A9C81118AB1C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 218,095,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 218,095,000 United States…, claim clm_74FB230D7BFA · ended · superseded by clm_246A631757AE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 1,384,966,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 1,384,966,000 United States dollar, claim clm_751B22F9EDDB · ended · superseded by clm_76C027BAF647 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 337,532,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 337,532,000 United States…, claim clm_75860C5404D3 · ended · superseded by clm_C5F9C8D7CC95 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 256,797,187 shares
Vertex Pharmaceuticals shares outstanding: 256,797,187 shares, claim clm_7659E4652BD8 · ended · superseded by clm_ABBFFDB9DFAC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 1,995,893,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 1,995,893,000 United States dollar, claim clm_765AB85FE8D8 · ended · superseded by clm_ADD73E1FB943 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -64,931,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -64,931,000 United States dollar, claim clm_76A2F176E63C · ended · superseded by clm_F8030CD50108 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 1,665,412,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 1,665,412,000 United States dollar, claim clm_76C027BAF647 · ended · superseded by clm_765AB85FE8D8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 580,415,000 United States dollar
Vertex Pharmaceuticals revenue: 580,415,000 United States dollar, claim clm_76E972477DD6 · ended · superseded by clm_B9A0D3A94E4B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 272,370,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 272,370,000 United States…, claim clm_77AD1FA686BE · ended · superseded by clm_90976FB1C473 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,986,900,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,986,900,000 United States dollar, claim clm_78B1FE0A2ECC · ended · superseded by clm_600A80B3AFE0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 1,035,300,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 1,035,300,000 United States dollar, claim clm_78BFE90ACA99 · ended · superseded by clm_33B55A456707 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 211,061,148 shares
Vertex Pharmaceuticals shares outstanding: 211,061,148 shares, claim clm_78F55C9D6D48 · ended · superseded by clm_F20A5D8DC03B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · 2,711,647,000 United States dollar
Vertex Pharmaceuticals net income: 2,711,647,000 United States dollar, claim clm_79102BFD0743 · ended · superseded by clm_F3A2B9FC81F1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 752,157,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 752,157,000 United States dollar, claim clm_7A545FD3F361 · ended · superseded by clm_8E2ABC809D39 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 637,416,000 United States dollar
Vertex Pharmaceuticals research and development: 637,416,000 United States dollar, claim clm_7AB4898F104F · ended · superseded by clm_7FB96A1EC04F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 258,053,387 shares
Vertex Pharmaceuticals shares outstanding: 258,053,387 shares, claim clm_7CB6DBDB3720 · ended · superseded by clm_2E5075D7DBE3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 714,718,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 714,718,000 United States dollar, claim clm_7D8A031A80DB · ended · superseded by clm_F514C594F662 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 930,498,000 United States dollar
Vertex Pharmaceuticals total equity: 930,498,000 United States dollar, claim clm_7DA2AEFA0080 · ended · superseded by clm_72E671723425 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 16,512,800,000 United States dollar
Vertex Pharmaceuticals total equity: 16,512,800,000 United States dollar, claim clm_7E2CD975D5FB · ended · superseded by clm_89548106AA99 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · fiscal year end · 12-31
Vertex Pharmaceuticals fiscal year end: 12-31, claim clm_7E8737D65987 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,186,200,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,186,200,000 United States dollar, claim clm_7EF8A5505C22 · ended · superseded by clm_B8F364B1BB32 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 707,706,000 United States dollar
Vertex Pharmaceuticals research and development: 707,706,000 United States dollar, claim clm_7FB96A1EC04F · ended · superseded by clm_CA9105114287 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 328,368,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 328,368,000 United States dollar, claim clm_7FF4DCB7FD4C · ended · superseded by clm_FF8C09587BDA · 1 source (1 primary) · conf 0.95

What the statuses mean